Crosstree Capital Partners is an investment banking firm specializing in the health sciences and life sciences sectors. Founded to focus exclusively on these industries, Crosstree operates primarily in North America and has a strong presence in key global healthcare markets.
The firm provides a range of investment banking services, including mergers and acquisitions (M&A) advisory, recapitalization, and strategic advisory services tailored to healthcare companies. Their expertise covers diverse sub-sectors, specifically pharma services, diagnostics and tools, and healthcare technology.
Crosstree has positioned itself as a leading advisor in M&A transactions within the health sciences sector, executing numerous high-profile deals and achieving rankings among the top firms in pharma services advisory. With a dedicated team of professionals, they leverage deep industry knowledge and extensive networks to facilitate optimal outcomes for their clients. The firm's focus on health sciences allows it to maintain a competitive advantage, executing transactions at a scale disproportionately larger than its size would suggest.
By using this website, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.